Idenix Leads Baupost To Best Month In Five Years; Klarman Explains Bio-tech Investments – ValueWalk Premium

Idenix Leads Baupost To Best Month In Five Years; Klarman Explains Bio-tech Investments

In the second quarter letter, Klarman spoke of the profits it made on investments such as Idenix Pharmaceuticals Inc (NASDAQ:IDIX). The biotech company helped make June Baupost's best month in five years. Idenix was acquired by Merck & Co., Inc. (NYSE:MRK)'s wholly-owned subsidiary Imperial Blue Corporation. Baupost

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk
0